首页> 美国卫生研究院文献>Scientific Reports >Rice bran extract supplement improves sleep efficiency and sleep onset in adults with sleep disturbance: A randomized double-blind placebo-controlled polysomnographic study
【2h】

Rice bran extract supplement improves sleep efficiency and sleep onset in adults with sleep disturbance: A randomized double-blind placebo-controlled polysomnographic study

机译:米糠提取物补充剂可改善患有睡眠障碍的成年人的睡眠效率和睡眠发作:一项随机双盲安慰剂对照的多导睡眠图研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We previously reported that rice bran extract supplement (RBS) administration to mice decreased sleep latency and induced non-rapid eye movement (NREM) sleep via inhibition of the histamine H1 receptor. Based on this, we performed the first clinical trial to investigate whether RBS would be beneficial to subjects with disturbed sleep. We performed a randomized, double‐blinded, placebo‐controlled, 2-week study. Fifty subjects with sleep disturbance were enrolled and received either RBS (1,000 mg/day) or placebo. Polysomnography was performed, and Pittsburgh Sleep Quality Index, Epworth Sleepiness Scale (ESS), and Fatigue Severity Scale were administered at the initiation and termination of the study. Compared with the placebo, RBS led to significant polysomnographic changes, including decreased sleep latency (adjusted, P = 0.047), increased total sleep time (P = 0.019), and improved sleep efficiency (P = 0.010). Additionally, the amount of stage 2 sleep significantly increased in the RBS group. When adjusted for caffeine intake, wakefulness after sleep onset, total wake time, and delta activity tended to decrease in the RBS group. RBS administration decreased ESS scores. There were no reported serious adverse events in both groups. RBS improved sleep in adults with sleep disturbance. Trial registration: WHO ICTRP, KCT0001893.
机译:我们以前曾报道过,向小鼠施用米糠提取物补充剂(RBS)可以降低睡眠潜伏期,并通过抑制组胺H1受体来诱导非快速眼动(NREM)睡眠。基于此,我们进行了第一项临床试验,以研究RBS是否对睡眠障碍的受试者有益。我们进行了一项随机,双盲,安慰剂对照的2周研究。入选了50名睡眠障碍的受试者,并接受RBS(1,000μg/天)或安慰剂。进行了多导睡眠监测,并在研究开始和结束时进行了匹兹堡睡眠质量指数,爱泼华嗜睡量表(ESS)和疲劳严重程度量表。与安慰剂相比,RBS导致多导睡眠图显着变化,包括睡眠潜伏期缩短(调整后,P = 0.047),总睡眠时间增加(P = 0.019)和改善的睡眠效率(P = 0.010)。此外,RBS组的第二阶段睡眠量显着增加。调整咖啡因摄入量后,RBS组的睡眠开始后的清醒,总苏醒时间和δ活性趋于降低。 RBS管理降低了ESS评分。两组均未报告严重不良事件。 RBS改善了患有睡眠障碍的成年人的睡眠。试用注册:WHO ICTRP,KCT0001893。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号